S1-Fc vaccine

candidate vaccine

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Vaccine

Drug status

Experimental

2
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

CHO-expressed recombinant SARS-CoV-2 S1-Fc fusion protein

 


Supporting references

Link Tested on Impact factor Notes Publication date
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates
Spike protein
mice, rabbits, monkeys 3.14

CHO-expressed S1-Fc protein is very immunogenic in various animals and can rapidly induce strong antibody production.

S1-Fc protein solicits strong neutralizing activities against live virus.

Jul/31/2020
A Targeted Vaccine against COVID-19: S1-Fc Vaccine Targeting the Antigen-Presenting Cell Compartment Elicits Protection against SARS-CoV-2 Infection
Preprint
murine cells Jun/30/2020